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lpha1-antitrypsin (AAT) is a serine protease
inhibitor that prevents enzymatic degrada-
tion of normal human tissue.1 The Z allele of
the AAT gene locus (designated PI ) is the most
frequent deficient mutation, with the PiZZ
phenotype responsible for 95% of severe AAT
deficiency cases.2 Severe deficiency is often under-
diagnosed and classically leads to pulmonary
and hepatic disease. Panniculitis is an unusual
complication of AAT deficiency with prevalence of
less than 0.1%.3 The panniculitis is characterized by
refractory, painful nodules that ulcerate with oily
or sanguineous drainage.4 We describe a unique
inflammatory presentation of AAT deficiency that
was characterized by recurrent fevers, ulcerative
panniculitis, and pleural effusions. The classic find-
ings of emphysema, bronchiectasis, and overt liver
injury were absent.Fig 1. Panniculitis of AAT deficiency. A, Tender, ill
flaccid bulla and small central ulcerationwith serou
to atrophic scars after 3 infusions of augmentation t
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A previously healthy, 38-year-old man (with
distant smoking history) presented with 5 months
of severe fatigue, fever, myalgias, arthralgias, and
joint swelling, which began shortly after a fishing
trip. These symptoms were accompanied by pain-
ful, ulcerating plaques of his upper and lower
extremities (Fig 1, A). The patient’s condition was
refractory to numerous courses of intravenous
antibiotics and systemic corticosteroids. Physical
examination of the ankles and arms found several
ill-defined, purpuric, ulcerative, edematous pla-
ques with yellow serous drainage. Clinical-defined, edematous, violaceous plaque with
s drainage on upper extremity. B, Progression
herapy in combination with dapsone.
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Fig 2. Histopathologic features of AAT deficiencyerelated
panniculitis. Septal panniculitis with a lymphocyte pre-
dominant inflammatory infiltrate, scattered histiocytes,
and septal widening of the subcutaneous fat. No evidence
of vasculitis or well-formed granulomas. (right arm;
hematoxylin-eosin stain; original magnification: 310.)
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2 Yu et aldifferential diagnosis was broad, including infec-
tious, inflammatory, vasculitic, thrombotic, and
embolic etiologies. An extensive rheumatologic
and infectious workup was negative, including
serologies and blood and tissue cultures.
Skin biopsy showed a septal panniculitis with a
lymphocyte-predominant infiltrate. Scattered nec-
rotic keratinocytes were observed in the epidermis
and acrosyringia (Fig 2). Vasculitis and necrosis were
not found. Infectious stains were negative.
The patient was found to have an AAT level of 43
mg/dL (normal, 83-199 mg/dL). Subsequent genetic
testing showed that the patient was homozygous for
the Z allele. Accordingly, AAT deficiency PiZZ
phenotype was diagnosed. Results of liver function
tests were normal. A computed tomography scan of
the abdomen and pelvis showed minimal hepatic
steatosis. Chest computed tomography showed
no evidence of emphysema or bronchiectasis.
However, the patient later developed recurrent and
bilateral, neutrophil predominant, exudative pleural
effusions that required multiple thoracenteses.
The patient was treated initially with dapsone,
100 mg by mouth daily, resulting in slight
clinical improvement. Remarkable systemic and
dermatologic improvement was observed after
initiation of intravenous a1-proteinase inhibitor
replacement protein administered at 60 mg/kg/wk.
The patient’s ulcerated plaques progressed to
atrophic scars after 3 infusions of augmentationtherapy (Fig 1, B), and the patient’s pleural effusions
resolved.DISCUSSION
AAT deficiency is an underdiagnosed genetic
disorder that rarely first presents on the skin.5
Morphology is nonspecific and can resemble cellu-
litis, vasculitis, or chronic ulcers.1,4 Fever commonly
leads to misdiagnosis as infection. Similarly, histopa-
thology can be variable, as septal panniculitis
may be present with or without lobular involvement
and fat necrosis.4 Although the characteristic
feature of AAT deficiency-related panniculitis is the
presence of neutrophils and liquefactive necrosis of
the dermis and fibrous septa,4 this may not
necessarily be observed in early lesions. Dapsone at
50 to 150 mg by mouth daily for several weeks
alone or combined with intravenous infusions
of AAT ameliorates panniculitis in AAT-deficient
patients.5
Although our patient possessed the severe
phenotype of the disease, he lacked numerous
diagnostic features of AAT deficiency: (1) a neutro-
philic infiltrate and necrosis on biopsy of the
panniculitis, (2) emphysema or bronchiectasis,
and (3) evidence of liver injury or cirrhosis.
Instead, our patient exhibited recurring,
neutrophil-rich bilateral pleural effusions, which
are uncommon in AAT deficiency. This case high-
lights that unexplained panniculitis in the setting of
fever and other signs of systemic inflammation
should prompt suspicion for AAT deficiency.REFERENCES
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